Skip to content
Disclosery

Parkman Healthcare Partners LLC

Follow

13F filer, CIK 1777015, STAMFORD, CT

Parkman Healthcare Partners LLC reported $1,050,473,314 across 100 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 32.3% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-000499

Period
2025-12-31
Reported value
$1.05B
Holdings
100
Top 10 weight
32.3%
New
20
Sold out
11

Largest buys vs the previous quarter

SecurityShares changeApprox. value
DXCMadded+415,847$27.6M
MASInew+200,000$26M
EYPTnew+1,088,033$19.9M
WATnew+41,899$15.9M
MTDnew+10,988$15.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BIIBreduced-94,740-$16.7M
ALNYreduced-39,987-$15.9M
TERNreduced-313,883-$12.7M
CSTLreduced-325,010-$12.6M
DHRreduced-51,652-$11.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001420506-26-000499, largest first. % of portfolio is the value over $1,050,473,314, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 447,196 shares; 2024Q4: 337,354 shares; 2025Q1: 225,990 shares; 2025Q2: 283,166 shares; 2025Q3: 434,377 shares; 2025Q4: 500,529 shares 500,529$47.7M4.54%+66,152Timeline
PODDINSULET CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 159,689 shares; 2024Q4: 125,761 shares; 2025Q1: 130,514 shares; 2025Q2: 105,762 shares; 2025Q3: 116,238 shares; 2025Q4: 140,860 shares 140,860$40M3.81%+24,622Timeline
DXCMDEXCOM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 70,588 shares; 2024Q4: 78,550 shares; 2025Q1: 130,367 shares; 2025Q2: 225,875 shares; 2025Q3: 171,628 shares; 2025Q4: 587,475 shares 587,475$39M3.71%+415,847Timeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 28,000 shares; 2024Q4: 77,717 shares; 2025Q1: 77,690 shares; 2025Q2: 50,376 shares; 2025Q3: 64,108 shares; 2025Q4: 105,472 shares 105,472$37.1M3.53%+41,364Timeline
CVSCVS HEALTH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 180,000 shares; 2025Q1: 496,736 shares; 2025Q2: 517,807 shares; 2025Q3: 379,486 shares; 2025Q4: 450,212 shares 450,212$35.7M3.4%+70,726Timeline
MCKMCKESSON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 23,000 shares; 2025Q1: 22,101 shares; 2025Q2: 17,458 shares; 2025Q3: 28,542 shares; 2025Q4: 36,355 shares 36,355$29.8M2.84%+7,813Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 753,752 shares; 2025Q2: 679,063 shares; 2025Q3: 1,735,003 shares; 2025Q4: 1,768,508 shares 1,768,508$28.6M2.72%+33,505Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 170,000 shares; 2025Q1: 328,323 shares; 2025Q2: 871,933 shares; 2025Q3: 773,304 shares; 2025Q4: 885,639 shares 885,639$27.9M2.66%+112,335Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 755,244 shares; 2024Q4: 765,453 shares; 2025Q1: 762,621 shares; 2025Q2: 488,796 shares; 2025Q3: 671,592 shares; 2025Q4: 665,208 shares 665,208$27.4M2.61%-6,384Timeline
MASIMASIMO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 200,000 shares 200,000$26M2.48%newTimeline
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 101,729 shares; 2024Q4: 174,934 shares; 2025Q1: 166,871 shares; 2025Q2: 175,000 shares; 2025Q3: 275,811 shares; 2025Q4: 410,912 shares 410,912$25.3M2.41%+135,101Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 545,751 shares; 2024Q4: 829,105 shares; 2025Q1: 959,703 shares; 2025Q2: 817,808 shares; 2025Q3: 934,760 shares; 2025Q4: 620,877 shares 620,877$25.1M2.39%-313,883Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 425,000 shares; 2024Q4: 1,087,634 shares; 2025Q1: 1,064,506 shares; 2025Q2: 1,298,825 shares; 2025Q3: 1,154,487 shares; 2025Q4: 788,076 shares 788,076$24.5M2.33%-366,411Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,025,754 shares; 2024Q4: 1,273,789 shares; 2025Q1: 1,215,629 shares; 2025Q2: 599,610 shares; 2025Q3: 652,680 shares; 2025Q4: 968,602 shares 968,602$23.1M2.2%+315,922Timeline
UPBUPSTREAM BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 233,563 shares; 2025Q2: 715,504 shares; 2025Q3: 843,502 shares; 2025Q4: 834,559 shares 834,559$22.7M2.16%-8,943Timeline
QIAGEN N.V.QIAGEN N.V.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 359,644 shares; 2025Q2: 498,107 shares; 2025Q3: 500,159 shares; 2025Q4: 494,351 shares 494,351$22.2M2.12%-5,808
FOLDAMICUS THERAPEUTICQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 605,318 shares; 2024Q4: 784,376 shares; 2025Q1: 568,952 shares; 2025Q2: 608,637 shares; 2025Q3: 1,687,318 shares; 2025Q4: 1,487,283 shares 1,487,283$21.2M2.02%-200,035Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,088,033 shares 1,088,033$19.9M1.89%newTimeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,485 shares; 2024Q4: 38,672 shares; 2025Q1: 68,938 shares; 2025Q2: 92,338 shares; 2025Q3: 87,690 shares; 2025Q4: 47,703 shares 47,703$19M1.81%-39,987Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,840 shares; 2024Q4: 115,727 shares; 2025Q1: 168,382 shares; 2025Q2: 166,010 shares; 2025Q3: 141,822 shares; 2025Q4: 114,712 shares 114,712$16.3M1.55%-27,110Timeline
WATWATERS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,899 shares 41,899$15.9M1.51%newTimeline
MTDMETTLER TOLEDO INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,988 shares 10,988$15.3M1.46%newTimeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 293,928 shares; 2025Q2: 463,601 shares; 2025Q3: 455,523 shares; 2025Q4: 410,249 shares 410,249$14.9M1.42%-45,274Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,000 shares; 2025Q4: 430,155 shares 430,155$13.7M1.3%+180,155Timeline
AAGILENT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares 100,000$13.6M1.3%newTimeline
ZBHZIMMER BIOMET HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 200,500 shares; 2025Q2: 240,395 shares; 2025Q3: 251,420 shares; 2025Q4: 151,049 shares 151,049$13.6M1.29%-100,371Timeline
DHRDANAHER CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 63,250 shares; 2025Q2: 110,090 shares; 2025Q3: 110,541 shares; 2025Q4: 58,889 shares 58,889$13.5M1.28%-51,652Timeline
XERSXERIS BIOPHARMA HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 102,393 shares; 2024Q4: 578,511 shares; 2025Q1: 1,780,454 shares; 2025Q2: 2,107,483 shares; 2025Q3: 1,791,674 shares; 2025Q4: 1,691,585 shares 1,691,585$13.3M1.26%-100,089Timeline
EWEDWARDS LIFESCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 145,214 shares; 2025Q1: 200,819 shares; 2025Q2: 251,741 shares; 2025Q3: 155,766 shares; 2025Q4: 150,985 shares 150,985$12.9M1.23%-4,781Timeline
PTCTPTC THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 195,000 shares; 2024Q4: 177,368 shares; 2025Q1: 280,314 shares; 2025Q2: 181,643 shares; 2025Q3: 202,363 shares; 2025Q4: 160,179 shares 160,179$12.2M1.16%-42,184Timeline
WAYWAYSTAR HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 140,000 shares; 2025Q3: 306,027 shares; 2025Q4: 369,023 shares 369,023$12.1M1.15%+62,996Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 508,283 shares; 2024Q4: 526,973 shares; 2025Q1: 594,987 shares; 2025Q2: 867,813 shares; 2025Q3: 846,899 shares; 2025Q4: 574,023 shares 574,023$12.1M1.15%-272,876Timeline
THCTENET HEALTHCARE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 93,753 shares; 2024Q4: 106,987 shares; 2025Q1: 213,418 shares; 2025Q2: 168,884 shares; 2025Q3: 74,330 shares; 2025Q4: 60,514 shares 60,514$12M1.14%-13,816Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,400 shares; 2024Q4: 23,588 shares; 2025Q1: 109,988 shares; 2025Q2: 119,623 shares; 2025Q3: 120,190 shares; 2025Q4: 118,712 shares 118,712$11.9M1.14%-1,478Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 105,000 shares; 2025Q2: 128,478 shares; 2025Q3: not reported; 2025Q4: 145,000 shares 145,000$11.4M1.09%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 657,070 shares; 2024Q4: 381,173 shares; 2025Q1: 425,407 shares; 2025Q2: 647,331 shares; 2025Q3: 550,173 shares; 2025Q4: 427,690 shares 427,690$10.6M1.01%-122,483Timeline
UNHUNITEDHEALTH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,000 shares; 2025Q1: 50,213 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 31,875 shares 31,875$10.5M1%newTimeline
COOCOOPER COS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 292,593 shares; 2024Q4: 274,569 shares; 2025Q1: 312,650 shares; 2025Q2: 385,479 shares; 2025Q3: 176,523 shares; 2025Q4: 125,335 shares 125,335$10.3M0.98%-51,188Timeline
AORTARTIVION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 111,652 shares; 2025Q2: 192,705 shares; 2025Q3: 221,044 shares; 2025Q4: 218,669 shares 218,669$9.97M0.95%-2,375Timeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 85,000 shares; 2025Q1: 46,663 shares; 2025Q2: 55,404 shares; 2025Q3: 105,831 shares; 2025Q4: 130,069 shares 130,069$9.82M0.93%+24,238Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 209,266 shares 209,266$8.67M0.83%+9,266Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 250,981 shares; 2025Q4: 249,357 shares 249,357$8.48M0.81%-1,624Timeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 66,492 shares; 2024Q4: 44,492 shares; 2025Q1: 67,390 shares; 2025Q2: 174,276 shares; 2025Q3: 149,848 shares; 2025Q4: 128,111 shares 128,111$8.35M0.8%-21,737Timeline
AXGNAXOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 412,888 shares; 2024Q4: 365,703 shares; 2025Q1: 536,832 shares; 2025Q2: 674,551 shares; 2025Q3: 501,832 shares; 2025Q4: 250,318 shares 250,318$8.19M0.78%-251,514Timeline
IQVIQVIA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 109,500 shares; 2025Q3: 30,000 shares; 2025Q4: 35,230 shares 35,230$7.94M0.76%+5,230Timeline
SIBNSI BONE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 185,316 shares; 2024Q4: 216,600 shares; 2025Q1: 231,109 shares; 2025Q2: 362,008 shares; 2025Q3: 378,583 shares; 2025Q4: 374,382 shares 374,382$7.38M0.7%-4,201Timeline
DOCSDOXIMITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 93,500 shares; 2025Q2: 120,834 shares; 2025Q3: 178,970 shares; 2025Q4: 162,276 shares 162,276$7.19M0.68%-16,694Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 464,048 shares; 2024Q4: 216,881 shares; 2025Q1: 1,000,562 shares; 2025Q2: 1,007,992 shares; 2025Q3: 1,012,664 shares; 2025Q4: 900,057 shares 900,057$7.02M0.67%-112,607Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 191,658 shares; 2024Q4: 193,004 shares; 2025Q1: 174,576 shares; 2025Q2: 150,373 shares; 2025Q3: 176,137 shares; 2025Q4: 154,184 shares 154,184$6.91M0.66%-21,953Timeline
OPRXOPTIMIZERX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 475,000 shares; 2025Q2: 507,423 shares; 2025Q3: 509,611 shares; 2025Q4: 538,649 shares 538,649$6.6M0.63%+29,038Timeline
ADPTADAPTIVE BIOTECHNOLOGIES CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 401,730 shares 401,730$6.52M0.62%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,165 shares; 2025Q4: 35,425 shares 35,425$6.23M0.59%-94,740Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 275,000 shares; 2025Q1: 203,833 shares; 2025Q2: 443,422 shares; 2025Q3: 345,356 shares; 2025Q4: 257,382 shares 257,382$6.16M0.59%-87,974Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 924,140 shares; 2024Q4: 1,000,474 shares; 2025Q1: 1,043,162 shares; 2025Q2: 500,000 shares; 2025Q3: 301,746 shares; 2025Q4: 645,544 shares 645,544$6.02M0.57%+343,798Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 351,131 shares; 2025Q4: 277,812 shares 277,812$5.97M0.57%-73,319Timeline
CSTLCASTLE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 296,071 shares; 2024Q4: 304,629 shares; 2025Q1: 350,551 shares; 2025Q2: 352,262 shares; 2025Q3: 475,568 shares; 2025Q4: 150,558 shares 150,558$5.86M0.56%-325,010Timeline
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 396,336 shares; 2024Q4: 228,334 shares; 2025Q1: 446,106 shares; 2025Q2: 648,871 shares; 2025Q3: 696,980 shares; 2025Q4: 277,181 shares 277,181$5.83M0.56%-419,799Timeline
TMDXTRANSMEDICS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,174 shares 45,174$5.5M0.52%newTimeline
SDGRSCHRODINGER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 559,105 shares; 2024Q4: 563,091 shares; 2025Q1: 481,470 shares; 2025Q2: 587,556 shares; 2025Q3: 340,187 shares; 2025Q4: 298,939 shares 298,939$5.35M0.51%-41,248Timeline
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 75,000 shares; 2024Q4: 175,415 shares; 2025Q1: 183,678 shares; 2025Q2: 386,646 shares; 2025Q3: 252,817 shares; 2025Q4: 184,491 shares 184,491$5.27M0.5%-68,326Timeline
CDNACAREDX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 276,154 shares 276,154$5.2M0.5%newTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 175,000 shares; 2025Q3: 45,250 shares; 2025Q4: 39,272 shares 39,272$5.11M0.49%-5,978Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 76,125 shares; 2025Q2: 116,343 shares; 2025Q3: 96,737 shares; 2025Q4: 100,564 shares 100,564$5.09M0.48%+3,827Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,458,652 shares 1,458,652$5.09M0.48%newTimeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 650,000 shares; 2025Q3: 579,174 shares; 2025Q4: 381,760 shares 381,760$4.61M0.44%-197,414Timeline
NSPRINSPIREMD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 104,081 shares; 2024Q4: 854,716 shares; 2025Q1: 1,171,416 shares; 2025Q2: 1,235,305 shares; 2025Q3: 2,440,633 shares; 2025Q4: 2,416,518 shares 2,416,518$4.3M0.41%-24,115Timeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,260 shares; 2024Q4: 100,301 shares; 2025Q1: 166,278 shares; 2025Q2: 220,387 shares; 2025Q3: 223,065 shares; 2025Q4: 100,269 shares 100,269$4.22M0.4%-122,796Timeline
PGENPRECIGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,191,343 shares; 2025Q2: 1,542,823 shares; 2025Q3: 2,101,715 shares; 2025Q4: 1,002,826 shares 1,002,826$4.19M0.4%-1,098,889Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,753 shares; 2025Q4: 124,485 shares 124,485$4.08M0.39%-76,268Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 347,541 shares; 2024Q4: 369,861 shares; 2025Q1: 393,153 shares; 2025Q2: 176,702 shares; 2025Q3: 402,595 shares; 2025Q4: 168,768 shares 168,768$3.95M0.38%-233,827Timeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,285 shares 25,285$3.95M0.38%newTimeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 55,000 shares 55,000$3.83M0.36%newTimeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 503,431 shares 503,431$3.78M0.36%+303,431Timeline
RXSTRXSIGHT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 184,320 shares; 2024Q4: 300,698 shares; 2025Q1: 631,238 shares; 2025Q2: 633,874 shares; 2025Q3: 380,713 shares; 2025Q4: 351,655 shares 351,655$3.66M0.35%-29,058Timeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 200,000 shares 200,000$3.65M0.35%newTimeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,304,085 shares; 2024Q4: 3,126,727 shares; 2025Q1: 2,493,836 shares; 2025Q2: 1,900,918 shares; 2025Q3: 656,084 shares; 2025Q4: 640,356 shares 640,356$3.63M0.35%-15,728Timeline
CAICARIS LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 125,000 shares 125,000$3.37M0.32%newTimeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,086,067 shares; 2024Q4: 1,117,792 shares; 2025Q1: 954,071 shares; 2025Q2: 827,060 shares; 2025Q3: 339,764 shares; 2025Q4: 86,297 shares 86,297$3.3M0.31%-253,467Timeline
CERTCERTARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: 551,850 shares; 2025Q4: 348,750 shares 348,750$3.07M0.29%-203,100Timeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 328,613 shares; 2024Q4: 330,849 shares; 2025Q1: 351,436 shares; 2025Q2: 404,194 shares; 2025Q3: 405,953 shares; 2025Q4: 601,202 shares 601,202$3.02M0.29%+195,249Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 682,897 shares; 2024Q4: 921,174 shares; 2025Q1: 1,229,522 shares; 2025Q2: 789,099 shares; 2025Q3: 491,408 shares; 2025Q4: 413,018 shares 413,018$2.93M0.28%-78,390Timeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 285,099 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,380 shares; 2025Q4: 99,604 shares 99,604$2.71M0.26%-776Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 396,396 shares; 2025Q4: 418,371 shares 418,371$2.36M0.22%+21,975Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 61,596 shares; 2025Q3: 61,849 shares; 2025Q4: 25,973 shares 25,973$2.27M0.22%-35,876Timeline
QTRXQUANTERIX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 515,992 shares; 2025Q3: 252,211 shares; 2025Q4: 328,956 shares 328,956$2.09M0.2%+76,745Timeline
LUNGPULMONX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 206,444 shares; 2024Q4: 207,853 shares; 2025Q1: 611,875 shares; 2025Q2: 605,029 shares; 2025Q3: 500,662 shares; 2025Q4: 727,781 shares 727,781$1.61M0.15%+227,119Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 109,468 shares; 2024Q4: 100,159 shares; 2025Q1: 304,244 shares; 2025Q2: 147,980 shares; 2025Q3: 68,636 shares; 2025Q4: 62,030 shares 62,030$1.43M0.14%-6,606Timeline
ACHCACADIA HEALTHCARE COMPANY INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares 100,000$1.42M0.14%newTimeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 15,000 shares 15,000$1.38M0.13%newTimeline
SENSSENSEONICS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 206,793 shares 206,793$1.14M0.11%newTimeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 77,623 shares; 2024Q4: 51,133 shares; 2025Q1: 63,940 shares; 2025Q2: 73,412 shares; 2025Q3: 73,725 shares; 2025Q4: 22,852 shares 22,852$1.06M0.1%-50,873Timeline
RPIDRAPID MICRO BIOSYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 735,621 shares; 2025Q2: 913,443 shares; 2025Q3: 913,443 shares; 2025Q4: 354,465 shares 354,465$1.03M0.1%-558,978Timeline
MDLNMEDLINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,558 shares 20,558$863K0.08%newTimeline
ARAYACCURAY INC DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 852,012 shares 852,012$703K0.07%newTimeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: 99,472 shares 99,472$686K0.07%-528Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 411,076 shares; 2024Q4: 413,732 shares; 2025Q1: 439,632 shares; 2025Q2: 355,822 shares; 2025Q3: 280,822 shares; 2025Q4: 275,073 shares 275,073$534K0.05%-5,749Timeline
FOCLEDAP TMS S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 154,832 shares; 2024Q4: 154,832 shares; 2025Q1: 154,832 shares; 2025Q2: 154,832 shares; 2025Q3: 154,832 shares; 2025Q4: 154,832 shares 154,832$509K0.05%0Timeline
TMCITREACE MED CONCEPTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 713,539 shares; 2025Q2: 843,998 shares; 2025Q3: 847,675 shares; 2025Q4: 199,393 shares 199,393$489K0.05%-648,282Timeline
BFLYBUTTERFLY NETWORK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 750,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 602,192 shares; 2025Q4: 100,835 shares 100,835$383K0.04%-501,357Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 202,978 shares; 2025Q4: 201,036 shares 201,036$328K0.03%-1,942Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
QQQINVESCO QQQ TR80,000$48Mput
UTHRUNITED THERAPEUTICS CORP DEL22,000$9.22Mshares
INCYINCYTE CORP100,442$8.52Mshares
ASNDASCENDIS PHARMA A/S40,343$8.02Mshares
LLYELI LILLY & CO10,000$7.63Mshares
BMRNBIOMARIN PHARMACEUTICAL INC125,949$6.82Mshares
OMOUTSET MED INC454,512$6.42Mshares
ABVXABIVAX SA55,197$4.69Mshares
DVAXDYNAVAX TECHNOLOGIES CORP271,306$2.69Mshares
TVRDTVARDI THERAPEUTICS INC65,000$2.53Mshares
MASS908 DEVICES INC100,368$879Kshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-000499 base2026-02-17acceptance time not in the bulk data set